Abstract:The cellular decoding of receptor-induced signaling is based in part on the spatiotemporal activation pattern of PKC isoforms. Because classical and novel PKC isoforms contain diacylglycerol (DAG)-binding C1 domains, they may compete for DAG binding. We reasoned that a Ca2+-induced membrane association of classical PKCs may accelerate the DAG binding and thereby prevent translocation of novel PKCs. Simultaneous imaging of fluorescent PKC fusion proteins revealed that during receptor stimulation, PKCα accumulat… Show more
“…The faster generation of DAGs from phosphatidylinositol hydrolysis vs. phosphatidylcholine hydrolysis (Nishizuka, 1995) may predispose to activation of cPKCs instead of nPKCs. Evidence from other studies suggests that the more rapid kinetics of cPKC translocation is determined by the calcium transients (Oancea, 1998;Lenz et al, 2002;Gallegos et al, 2006). In summary, although phosphorylation at specific PKC sites in the I-II linker and C-terminus would seem to be sufficient for activation of Ca v 2.2 channels, in the Ca v 2.3 channels, these sites may be necessary but not sufficient.…”
Protein kinase C (PKC) is implicated in the potentiation of Ca v 2.3 currents by acetyl-β-methylcholine (MCh), a muscarinic M 1 receptor agonist or phorbol-12-myristate, 13-acetate (PMA). The PKC isozymes responsible for the action of MCh and PMA were investigated using translocation as a measure of activation and with isozyme-selective antagonists and siRNA. Ca v channels were expressed with α 1 2.3, β 1 b and α 2 δ subunits and muscarinic M 1 receptors in the Xenopus oocytes and the expressed currents (I Ba ) were studied using Ba 2+ as the charge carrier. Translocation of PKC isozymes to the membrane studied by Western blot revealed that all eleven known PKC isozymes are present in the Xenopus oocytes. Exposure of the oocytes to MCh led to the translocation of PKC α whereas PMA activated PKC βII and ε isozymes. The action of MCh was inhibited by Go 6976, an inhibitor of cPKC isozymes or PKC α siRNA. PMA-induced potentiation of Ca v 2.3 currents was inhibited by CG533 53, a PKC βII antagonist, βIIV5.3, a peptide translocation inhibitor of PKC βII or PKC βII siRNA. Similarly, εV1.2, a peptide translocation inhibitor of PKC ε or PKC ε siRNA inhibited PMA action. The inhibitors of PKC increased the basal I Ba slightly. It is possible that some PKC isozymes have negative control over the I Ba . Our results implicate PKC α in the potentiation of Ca v 2.3 currents by MCh and PKC βII and ε in the potentiation of Ca v 2.3 currents by PMA.
Classification of termsSection: 3. Neurophysiology, Neruopharmacology and other forms of Interceullular communication
“…The faster generation of DAGs from phosphatidylinositol hydrolysis vs. phosphatidylcholine hydrolysis (Nishizuka, 1995) may predispose to activation of cPKCs instead of nPKCs. Evidence from other studies suggests that the more rapid kinetics of cPKC translocation is determined by the calcium transients (Oancea, 1998;Lenz et al, 2002;Gallegos et al, 2006). In summary, although phosphorylation at specific PKC sites in the I-II linker and C-terminus would seem to be sufficient for activation of Ca v 2.2 channels, in the Ca v 2.3 channels, these sites may be necessary but not sufficient.…”
Protein kinase C (PKC) is implicated in the potentiation of Ca v 2.3 currents by acetyl-β-methylcholine (MCh), a muscarinic M 1 receptor agonist or phorbol-12-myristate, 13-acetate (PMA). The PKC isozymes responsible for the action of MCh and PMA were investigated using translocation as a measure of activation and with isozyme-selective antagonists and siRNA. Ca v channels were expressed with α 1 2.3, β 1 b and α 2 δ subunits and muscarinic M 1 receptors in the Xenopus oocytes and the expressed currents (I Ba ) were studied using Ba 2+ as the charge carrier. Translocation of PKC isozymes to the membrane studied by Western blot revealed that all eleven known PKC isozymes are present in the Xenopus oocytes. Exposure of the oocytes to MCh led to the translocation of PKC α whereas PMA activated PKC βII and ε isozymes. The action of MCh was inhibited by Go 6976, an inhibitor of cPKC isozymes or PKC α siRNA. PMA-induced potentiation of Ca v 2.3 currents was inhibited by CG533 53, a PKC βII antagonist, βIIV5.3, a peptide translocation inhibitor of PKC βII or PKC βII siRNA. Similarly, εV1.2, a peptide translocation inhibitor of PKC ε or PKC ε siRNA inhibited PMA action. The inhibitors of PKC increased the basal I Ba slightly. It is possible that some PKC isozymes have negative control over the I Ba . Our results implicate PKC α in the potentiation of Ca v 2.3 currents by MCh and PKC βII and ε in the potentiation of Ca v 2.3 currents by PMA.
Classification of termsSection: 3. Neurophysiology, Neruopharmacology and other forms of Interceullular communication
“…FRET from CFP to YFP was determined by excitation of CFP (425 nm) and measurement of fluorescence emitted from YFP (535/26 nm). The maximum FRET capability of the system was defined by determining FRET from CFP to YFP in a fusion protein consisting of the two proteins (42). Background fluorescence from a region with no cells was subtracted from the data.…”
“…Schaefer et al (31,32) suggested that differences in translocation between classical and novel PKCs are due to differences in diffusion rates, and collision efficiencies with the membrane. Although diffusion and collision with the membrane are likely factors in the translocation rate, our data demonstrate that conformational changes in the enzyme also occur, leading to at least a two-step process.…”
Section: Mathematical Modeling Of ⑀Pkc Translocation Suggests That ⑀Pmentioning
Disruption of intramolecular interactions, translocation from one intracellular compartment to another, and binding to isozyme-specific anchoring proteins termed RACKs, accompany protein kinase C (PKC) activation. We hypothesized that in inactive ⑀PKC, the RACK-binding site is engaged in an intramolecular interaction with a sequence resembling its RACK, termed⑀RACK. An amino acid difference between the ⑀RACK sequence in ⑀PKC and its homologous sequence in ⑀RACK constitutes a change from a polar non-charged amino acid (asparagine) in ⑀RACK to a polar charged amino acid (aspartate) in ⑀PKC. Here we show that mutating the aspartate to asparagine in ⑀PKC increased intramolecular interaction as indicated by increased resistance to proteolysis, and slower hormone-or PMAinduced translocation in cells. Substituting aspartate for a non-polar amino acid (alanine) resulted in binding to ⑀RACK without activators, in vitro, and increased translocation rate upon activation in cells. Mathematical modeling suggests that translocation is at least a two-step process. Together our data suggest that intramolecular interaction between the ⑀RACK site and RACK-binding site within ⑀PKC is critical and rate limiting in the process of PKC translocation.The protein kinase C (PKC) 1 family of phospholipid (PL) -dependent serine/threonine kinases undergoes a conformational change and translocation, or movement, from the cytosolic to the cell particulate fraction upon activation (1, 2). Conformational changes in PKC from an inactive to an active state results in exposure of domains required for PKC anchoring to the particulate fraction and in increased sensitivity of the enzyme to proteases (1-3, 41). Therefore, the inactive state exists in a closed conformation, with the proteolytic sites protected, whereas the active state is in an open conformation with exposed proteolytic sites. Structural alterations from the closed to open states involve disruption of intramolecular interactions within the enzyme.An intramolecular interaction in inactive PKC between the catalytic site and a site in the regulatory domain that resembles a substrate phosphorylation site but lacks a serine or threonine phosphoacceptor (pseudosubstrate site) has been previously identified (3, 6). Deletion of the pseudosubstrate ( -substrate) site generated a constitutively active enzyme (6) and mutations of the basic residues in the -substrate site reduced the affinity of the catalytic site to the -substrate site generating a constitutively active enzyme, preferentially localized to the cell particulate fraction (6). Furthermore, conversion of the alanine in the -substrate site to a glutamic acid, mimicking a phosphorylated amino acid, resulted in loss of binding of the -substrate site to the catalytic site, creating a constitutively active enzyme (6). Finally, a peptide corresponding to the -substrate site is a competitive inhibitor of PKC catalytic activity (6).We previously demonstrated that translocation of PKC is associated with binding of each activated PKC isozyme to...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.